Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating expenses:
Research and development	$ 29,584	$ 57,575
General and administrative	9,457	12,231
Total operating expenses	39,041	69,806
Loss from operations	(39,041)	(69,806)
Interest income and other, net	4,972	6,868
Loss before income taxes	(34,069)	(62,938)
Income tax expense	(203)	(231)
Net loss	(34,272)	(63,169)
Other comprehensive loss
Unrealized loss on available-for-sale investments	(115)	(388)
Comprehensive loss	$ (34,387)	$ (63,557)
Net loss per share - basic and diluted
Net loss per share - basic	$ (0.4)	$ (0.75)
Net loss per share - diluted	$ (0.4)	$ (0.75)
Weighted-average number of common shares - basic and diluted
Weighted-average number of common shares - basic	85,159,254	83,916,193
Weighted-average number of common shares - diluted	85,159,254	83,916,193